MedTrace Logo

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

NCT04985032 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2022-08-05

No results posted yet for this study

Summary

This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respiratory tracking. The study will accrue 200 patients who will be treated to a dose of 30 Gy over the course of 5 fractions. These subjects will then have a follow up time of 5 years

Conditions

  • Ductal Carcinoma in Situ
  • Invasive Ductal Carcinoma of Female Breast

Interventions

RADIATION

stereotactic body radiation therapy

Treatment technique used to deliver a highly focused and accurate radiation dose to a defined target volume outside the brain; the entire course of therapy delivered in five fractions or less

Sponsors & Collaborators

  • CyberKnife Coalition

    collaborator UNKNOWN

  • RPCR, Inc.

    lead OTHER

Eligibility

Min Age
50 Years
Max Age
100 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-08-15
Primary Completion
2024-08-15
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04985032 on ClinicalTrials.gov